The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HER2 quantification by mass spectrometry compared to IHC or ISH in predicting clinical benefit from anti-HER2 therapy in HER2-positive breast cancer (BC).
 
Paolo Nuciforo
Consulting or Advisory Role - Debiopharm Group; Novartis; Samsung Bioepis
 
Claudia Aura
No Relationships to Disclose
 
Sheeno P Thyparambil
Employment - OncoPlex Diagnostics
Stock and Other Ownership Interests - OncoPlex Diagnostics
Research Funding - OncoPlex Diagnostics
Patents, Royalties, Other Intellectual Property - OncoPlex Diagnostics
Travel, Accommodations, Expenses - OncoPlex Diagnostics
 
Marta Vilaro
No Relationships to Disclose
 
Ana C. Garrido-Castro
No Relationships to Disclose
 
Vicente Peg
Speakers' Bureau - Sysmex
Research Funding - Sysmex (Inst)
Travel, Accommodations, Expenses - Sysmex
 
Jose Jimenez
No Relationships to Disclose
 
William Arthur Hoos
Consulting or Advisory Role - OncoPlex Diagnostics
Travel, Accommodations, Expenses - OncoPlex Diagnostics
 
Jon Burrows
Employment - OncoPlex Diagnostics
Leadership - OncoPlex Diagnostics
Stock and Other Ownership Interests - OncoPlex Diagnostics
 
Todd A. Hembrough
Employment - OncoPlex Diagnostics
Leadership - OncoPlex Diagnostics
Stock and Other Ownership Interests - OncoPlex Diagnostics
Patents, Royalties, Other Intellectual Property - OncoPlex Diagnostics
 
Jose Manuel Perez-Garcia
No Relationships to Disclose
 
Javier Cortes
Honoraria - Celgene; Eisai; Novartis; Roche Pharma AG
Consulting or Advisory Role - Celgene; Roche Pharma AG
 
Maurizio Scaltriti
No Relationships to Disclose